A study from Denmark has unveiled taking aspirin in low-dose a day for at least five years have been linked to reduced risk of colorectal cancer. The research has tried to sort out the relationship between aspirin and non-steroidal anti-inflammatory drugs (NSAIDs), duration of treatment and colorectal cancer rates.

In the study, the researchers have gone through the data of more than 113,000 individuals. Study researchers were of the view that a daily dose of 75 to 150 milligram of aspirin for at least five years can reduce the risk of the disease by 27%.

If the drug is taken on continuous basis then it was associated with a decline in risk by 30 to 45%. Study’s lead researcher Dr. Soren Friis from the Danish Cancer Society Research Centre was of the view, “Our results indicate that if aspirin is taken at doses of 75 to 150mg, long-term, continuous use is necessary to achieve a substantial protective effect against colorectal (bowel) cancer”.

As per study researchers, there are different factors on the basis of risk of developing colorectal cancer depends like age, race, ethnicity and lifestyle. Generally, cases are diagnosed in people older than 50.

The Centers for Disease Control and Prevention has indicated that an average white or black woman in her late 50s faces risk of developing the cancer between 1 and 1.4%. In the case of men, it is around 1.4 and 5.8%.